This dual behavior is evident since genetic deletion of iNOS in a mouse model of AD promotes neurodegeneration [167], and iNOS inhibition could be an effective approach in treating AD and other neurodegenerative diseases [168]. This evidence concerns the gene NOS2 and neurodegenerative disease.